Krystal Biotech (KRYS) Shares Issued (2017 - 2026)

Krystal Biotech's Shares Issued history runs 10 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• In Q1 2026, Shares Issued rose 344.66% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $5.0 million (down 71.84% YoY), while the FY2024 annual figure was $32.4 million, down 79.72% from the prior year.
• Shares Issued came in at $6.5 million for Q1 2026 at Krystal Biotech, up from -$7.0 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $118.6 million in Q4 2023 to a low of -$7.0 million in Q4 2025.
• A 5-year average of $13.4 million and a median of $3.4 million in 2024 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued surged 15527.14% in 2022 and plunged 387.15% in 2025, its largest moves.
• Krystal Biotech's Shares Issued stood at -$3.9 million in 2022, then soared by 3109.95% to $118.6 million in 2023, then sank by 97.95% to $2.4 million in 2024, then slumped by 387.15% to -$7.0 million in 2025, then jumped by 193.24% to $6.5 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $6.5 million, -$7.0 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison